Published in Pediatr Allergy Immunol on May 01, 2008
Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J (2014) 1.74
Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03
T-cell responses induced by allergen-specific immunotherapy. Clin Exp Immunol (2010) 0.94
Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens. Clin Transl Allergy (2014) 0.93
On mechanism of action of sublingual immunotherapy. Pediatr Allergy Immunol (2009) 0.83
Current immunological approaches for management of allergic rhinitis and bronchial asthma. Inflamm Res (2009) 0.77
Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells. BMC Immunol (2012) 0.76
Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients. J Environ Public Health (2012) 0.76
Sublingual immunotherapy in asthma does not influence lymphocyte sensitivity to Fas stimulation. Eur J Med Res (2010) 0.75
Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response. Sci Rep (2015) 0.75
Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children. PLoS One (2017) 0.75
Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. J Allergy Clin Immunol (2009) 1.62
Basophil activation after nonsteroidal anti-inflammatory drugs stimulation in patients with immediate hypersensitivity reactions to these drugs. Cytometry A (2014) 1.60
Allergic reactions to beta-lactams. Expert Opin Drug Saf (2006) 1.42
Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol (2013) 1.39
Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol (2007) 1.30
Bovine tuberculosis in Doñana Biosphere Reserve: the role of wild ungulates as disease reservoirs in the last Iberian lynx strongholds. PLoS One (2008) 1.25
Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol (2002) 1.05
Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol (2013) 1.02
Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol (2006) 0.93
Role of dendritic cells in drug allergy. Curr Opin Allergy Clin Immunol (2011) 0.93
Pharmacogenomics in aspirin intolerance. Curr Drug Metab (2009) 0.92
Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma. Pediatr Allergy Immunol (2006) 0.89
Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol (2010) 0.88
Immunologic evaluation of drug allergy. Allergy Asthma Immunol Res (2012) 0.88
Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol (2009) 0.88
Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams. J Allergy Clin Immunol (2006) 0.87
Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age. Pediatr Infect Dis J (2008) 0.87
Recurrent transient ischaemic attack and early risk of stroke: data from the PROMAPA study. J Neurol Neurosurg Psychiatry (2013) 0.86
Immediate allergy to tetanus toxoid vaccine: determination of immunoglobulin E and immunoglobulin G antibodies to allergenic proteins. Ann Allergy Asthma Immunol (2003) 0.86
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J (2006) 0.86
Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol (2005) 0.86
IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response. J Neuroimmunol (2005) 0.85
Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone. Medicine (Baltimore) (2016) 0.82
Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen. J Allergy Clin Immunol (2011) 0.81
Interferon receptor expression in multiple sclerosis patients. J Neuroimmunol (2006) 0.80
Hypersensitivity reactions to beta-lactams. EXS (2014) 0.80
Angioedema induced by angiotensin-converting enzyme inhibitors. Curr Opin Allergy Clin Immunol (2013) 0.80
Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study. J Neurol (2002) 0.80
Synthesis, characterization and immunochemical evaluation of cephalosporin antigenic determinants. J Mol Recognit (2003) 0.80
Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin. Ann Allergy Asthma Immunol (2003) 0.79
Low 2-methoxyestradiol levels at the first trimester of pregnancy are associated with the development of pre-eclampsia. Prenat Diagn (2012) 0.79
Effect of Pru p 3 on dendritic cell maturation and T-lymphocyte proliferation in peach allergic patients. Ann Allergy Asthma Immunol (2012) 0.79
Allergic reactions to antibiotics in children. Curr Opin Allergy Clin Immunol (2014) 0.79
[Microbiological characterisation of Listeria monocytogenes isolates from human cases in Andalusia]. Enferm Infecc Microbiol Clin (2012) 0.79
Metabolomics in drug intolerance. Curr Drug Metab (2009) 0.77
The contribution of major and minor determinants from benzylpenicillin to the diagnosis of immediate allergy to beta-lactams. J Allergy Clin Immunol (2005) 0.77
Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville. Enferm Infecc Microbiol Clin (2012) 0.77
T-cell involvement in delayed-type hypersensitivity reactions to infliximab. J Allergy Clin Immunol (2011) 0.77
Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients. PLoS One (2013) 0.77
Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs. Pharmacogenomics (2013) 0.77
Role of the basophil activation test in the diagnosis of local allergic rhinitis. J Allergy Clin Immunol (2013) 0.77
Drug metabolism and hypersensitivity reactions to drugs. Curr Opin Allergy Clin Immunol (2015) 0.77
Generation of reactive intermediates in photoallergic dermatitis. Curr Opin Allergy Clin Immunol (2010) 0.77
Role of Histamine Release Test for the Evaluation of Patients with Immediate Hypersensitivity Reactions to Clavulanic Acid. Int Arch Allergy Immunol (2016) 0.76
Anaphylaxis induced by fosfomycin. Ann Allergy Asthma Immunol (2010) 0.76
Allergic Reactions to Metamizole: Immediate and Delayed Responses. Int Arch Allergy Immunol (2016) 0.76
Multivalent Glycosylation of Fluorescent Gold Nanoclusters Promotes Increased Human Dendritic Cell Targeting via Multiple Endocytic Pathways. ACS Appl Mater Interfaces (2015) 0.76
Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations. Pharmacogenomics (2013) 0.76
Mass spectrometric strategies for the identification and characterization of human serum albumin covalently adducted by amoxicillin: ex vivo studies. Chem Res Toxicol (2014) 0.76
Dendrimerized cellulose as a scaffold for artificial antigens with applications in drug allergy diagnosis. Biomacromolecules (2008) 0.76
Synthetic approach to gain insight into antigenic determinants of cephalosporins: in vitro studies of chemical structure-IgE molecular recognition relationships. Chem Res Toxicol (2011) 0.76
Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cells Mol Dis (2002) 0.76
Boosted IgE response after anaphylaxis reaction to cefuroxime with cross-reactivity with cefotaxime. Ann Allergy Asthma Immunol (2002) 0.76
Nonimmediate reactions to betalactams. Curr Opin Allergy Clin Immunol (2007) 0.76
Methodologies to anchor dendrimeric nanoconjugates to solid phase: toward an efficient in vitro detection of allergy to β-lactam antibiotics. Nanomedicine (2011) 0.75
Penicillin allergy is a global problem: the European experience. J Allergy Clin Immunol (2003) 0.75
[Personalized bioethics]. Cuad Bioet (2013) 0.75
Food allergy: management, diagnosis and treatment strategies. Immunotherapy (2013) 0.75
Cephalosporin allergy. N Engl J Med (2002) 0.75
Sublingual immunotherapy and oral mucosal langerhans cells. Immunotherapy (2011) 0.75
Genetic Predictors of Drug Hypersensitivity. Curr Pharm Des (2016) 0.75
Prediction of hypersensitivity to antibiotics: what factors need to be considered? Expert Rev Clin Immunol (2013) 0.75
Specific immunological response to budesonide in a patient with delayed-type hypersensitivity reaction. J Invest Dermatol (2009) 0.75
Anaphylaxis to Mare's milk. Ann Allergy Asthma Immunol (2007) 0.75
Contact dermatitis caused by bromide compounds. Contact Dermatitis (2013) 0.75
Diagnosing β-lactam hypersensitivity. Curr Pharm Des (2016) 0.75
Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms. Ann Allergy Asthma Immunol (2013) 0.75
Dendrimers as carrier protein mimetics for IgE antibody recognition. Synthesis and characterization of densely penicilloylated dendrimers. Bioconjug Chem (2002) 0.75